IT1255199B - Farmaco sintetizzato analogo della melatonina particolarmente efficacenelle patologie che interferiscono con i ritmi circadiani - Google Patents

Farmaco sintetizzato analogo della melatonina particolarmente efficacenelle patologie che interferiscono con i ritmi circadiani

Info

Publication number
IT1255199B
IT1255199B ITMI921612A ITMI921612A IT1255199B IT 1255199 B IT1255199 B IT 1255199B IT MI921612 A ITMI921612 A IT MI921612A IT MI921612 A ITMI921612 A IT MI921612A IT 1255199 B IT1255199 B IT 1255199B
Authority
IT
Italy
Prior art keywords
melatonin
particularly effective
interfer
pathologies
circadian rhythms
Prior art date
Application number
ITMI921612A
Other languages
English (en)
Inventor
Franco Fraschini
Aldo Laguzzi
Original Assignee
Franco Fraschini
Aldo Laguzzi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11363605&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1255199(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Franco Fraschini, Aldo Laguzzi filed Critical Franco Fraschini
Priority to ITMI921612A priority Critical patent/IT1255199B/it
Publication of ITMI921612A0 publication Critical patent/ITMI921612A0/it
Priority to AT93830269T priority patent/ATE187442T1/de
Priority to DE69327207T priority patent/DE69327207D1/de
Priority to EP93830269A priority patent/EP0585206B1/en
Priority to JP5159817A priority patent/JP2805575B2/ja
Publication of ITMI921612A1 publication Critical patent/ITMI921612A1/it
Priority to US08/196,380 priority patent/US5552428A/en
Application granted granted Critical
Publication of IT1255199B publication Critical patent/IT1255199B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Farmaco sintetizzato analogo della melatonina particolarmente efficace nelle patologie che interferiscono con i ritmi circadiani
ITMI921612A 1992-06-24 1992-07-01 Farmaco sintetizzato analogo della melatonina particolarmente efficacenelle patologie che interferiscono con i ritmi circadiani IT1255199B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ITMI921612A IT1255199B (it) 1992-07-01 1992-07-01 Farmaco sintetizzato analogo della melatonina particolarmente efficacenelle patologie che interferiscono con i ritmi circadiani
AT93830269T ATE187442T1 (de) 1992-07-01 1993-06-24 Tryptamine zur behandlung von störungen der circadianen rhythmik
DE69327207T DE69327207D1 (de) 1992-07-01 1993-06-24 Tryptamine zur Behandlung von Störungen der circadianen Rhythmik
EP93830269A EP0585206B1 (en) 1992-07-01 1993-06-24 Tryptamines for treatment of circadian rhythm disorders
JP5159817A JP2805575B2 (ja) 1992-07-01 1993-06-30 概日リズム治療用薬剤、これに用いる化合物およびその合成方法
US08/196,380 US5552428A (en) 1992-06-24 1994-02-15 Compounds effective in the treatment of circadian rhythms and related disorders, the novel pharmaceutical preparations and novel method of application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI921612A IT1255199B (it) 1992-07-01 1992-07-01 Farmaco sintetizzato analogo della melatonina particolarmente efficacenelle patologie che interferiscono con i ritmi circadiani

Publications (3)

Publication Number Publication Date
ITMI921612A0 ITMI921612A0 (it) 1992-07-01
ITMI921612A1 ITMI921612A1 (it) 1994-01-01
IT1255199B true IT1255199B (it) 1995-10-20

Family

ID=11363605

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI921612A IT1255199B (it) 1992-06-24 1992-07-01 Farmaco sintetizzato analogo della melatonina particolarmente efficacenelle patologie che interferiscono con i ritmi circadiani

Country Status (5)

Country Link
EP (1) EP0585206B1 (it)
JP (1) JP2805575B2 (it)
AT (1) ATE187442T1 (it)
DE (1) DE69327207D1 (it)
IT (1) IT1255199B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180657B1 (en) * 1993-11-18 2001-01-30 Eli Lilly And Company Melatonin derivatives for use in treating desynchronization disorders
US5654325A (en) * 1993-11-18 1997-08-05 Eli Lilly And Company Melatonin derivatives for use in treating sleep disorders
JPH09511334A (ja) * 1994-03-30 1997-11-11 チバ−ガイギー アクチェンゲゼルシャフト Ｒｚｒ受容体ファミリーを用いるスクリーニング方法
FR2737725B1 (fr) * 1995-08-08 1997-10-31 Valentonine Nouveaux derives acyles de la melatonine et d'analogues melatoninergiques, leur procede de preparation et leur utilisation en tant que medicament
AU1698899A (en) * 1997-11-04 1999-05-24 St. Elizabeth's Medical Center Of Boston, Inc. N-acetylserotonin derivatives and uses thereof
WO2005084664A1 (ja) * 2004-03-08 2005-09-15 Kanazawa University Technology Licensing Organization Ltd. インドール誘導体及びその用途
JP3964417B2 (ja) 2004-09-27 2007-08-22 国立大学法人金沢大学 インドール誘導体を有効成分とするα２受容体遮断剤及び血管拡張剤
MX2023002557A (es) * 2020-09-01 2023-05-29 Enveric Biosciences Canada Inc Derivados de psilocibina halogenada y metodos de uso.
CN113480467B (zh) * 2021-07-13 2022-12-30 河北维达康生物科技有限公司 一种放射性示踪剂2-碘褪黑素的合成工艺

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0126630B1 (en) * 1983-05-18 1987-09-16 Monash University The use of melatonin for the manufacture of a medicament
WO1989001472A1 (en) * 1987-08-17 1989-02-23 Nelson Research & Development Co. Melatonin analogues
EP0483077B1 (en) * 1990-09-28 1995-12-06 I.F.L.O. S.a.s. di Giorgio e Aldo Laguzzi A method for carrying out the synthesis of a contraceptive and menstrual cycle controlling drug having oncostatic, antikinetosic, preventive and therapeutic properties for treatment of mammary tumours and melanomas.
IT1251544B (it) * 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico

Also Published As

Publication number Publication date
DE69327207D1 (de) 2000-01-13
ATE187442T1 (de) 1999-12-15
ITMI921612A0 (it) 1992-07-01
EP0585206A1 (en) 1994-03-02
JP2805575B2 (ja) 1998-09-30
ITMI921612A1 (it) 1994-01-01
EP0585206B1 (en) 1999-12-08
JPH06183968A (ja) 1994-07-05

Similar Documents

Publication Publication Date Title
NO171209C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive morfinanestere
PT851855E (pt) Derivados acilados de melatonina e de analogos uteis como medicamentos
FI943625A0 (fi) Menetelmiä tulehduksellisten ihotautien hoitamiseksi
DE69034018D1 (de) Kombinierte verwendung von hyaluronsäure und therapeutischen wirkstoffen zur verbesserung des therapeutischen effekts
FI921232A7 (fi) Siilorehun entsyymaattinen käsittely
LU81153A1 (de) Verwendung von antioestrogenen und antigonadotrop wirkenden antiandrogenen zur prophylaxe und therapie der prostatahyperplasie
NO924461D0 (no) Dipyridamol for behandling av proliferaktive sykdommer
GR3022060T3 (en) Melatonin derivaties for use in the therapy of sleep disorders and in pre-anaesthetic medication
ES2045400T3 (es) Forma de dosificacion para suministrar un farmaco para la terapia humana.
IT1127322B (it) Composizioni farmaceutiche con esaltazione dell'attivita' terapeutica di cortisonici
NO172986C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte 9h-puriner
JPS5484546A (en) Substituted amide derivative of ll* dllphenylglycine*its manufacture and therapeutic medicine thereof
FI933902A7 (fi) Substituoidut sykloheksaanijohdannaiset sairauksien hoitamiseksi
IT7849358A0 (it) Procedimento per la cura farmacologica dell'abitudine alla droga con alfa-metil-para-tirosina
ITMI921612A0 (it) Farmaco sintetizzato analogo della melatonina particolarmente efficace nelle patologie che interferiscono con i ritmi circadiani
NO171679C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-3-(1-piperazinyl)-1h-indazoler
ITMI921556A1 (it) Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani
IT8312019A0 (it) Mezzo di autotrattamento elettroterapeutico del dolore e dell'insonnia ad associazione di campi
IT8720181A0 (it) Composizioni farmaceutiche contenenti alcoli superiori per il trattamento di patologie della prostata.
FI891986A7 (fi) Farmaseuttiset koostumukset psoriasiksen hoitoon
ES2068714T3 (es) Derivados de pirimidina para aumentar la actividad antitumoral.
GB8823297D0 (en) Wall-mounted luminaire for treatment of seasonal affective disorder
IT7820500A0 (it) Prieta' analgesiche, antinfiammatocomposizioni farmaceutiche con prorie e inibitrici della sintetasi di prostaglandina
IS4532A (is) Notkun Melatóníns til meðferðar lyfjafíkla
IT9021768A0 (it) Derivato della melatonina ad attivita' terapeutica in dermatologia

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960623